NETWORK META-ANALYSIS OF TOFACITINIB VS BDMARDS OR APREMILAST FOR THE TREATMENT OF TNF INHIBITOR-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS

被引：2
|
作者：
Gladman, D. D. [1 ]
Orbai, A. -M. [2 ]
Gomez-Reino, J. [3 ]
Chang-Douglass, S. [4 ]
Leoncini, E. [4 ]
Burton, H. E. [4 ]
Kanik, K. S. [5 ]
Hendrikx, T. [6 ]
Cappelleri, J. C. [5 ]
Hsu, M. -A. [5 ]
机构：
[1] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Hosp Clin Univ, Santiago De Compostela, Spain
[4] Decis Resources Grp, London, England
[5] Pfizer Inc, Groton, CT 06340 USA
[6] Pfizer Inc, Collegeville, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.4823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0300
引用
收藏
页码：368 / 369
页数：2
相关论文
共 50 条
  • [31] The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    Paweł Kawalec
    Alicja Mikrut
    Natalia Wiśniewska
    Andrzej Pilc
    Clinical Rheumatology, 2013, 32 : 1415 - 1424
  • [32] A Phosphodiesterase 4 Inhibitor for Psoriatic Arthritis: Systematic Review and Meta-Analysis
    Valerio-Morales, Ignacio-Alfredo
    Lopez-Olivo, Maria A.
    Pan, Xin
    Suarez-Almazor, Maria E.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis: a Systematic Review and Meta-Analysis
    He, Y.
    Wong, A.
    Chan, E.
    Lau, W.
    Man, K.
    Chui, C.
    Worsley, A.
    Wong, I.
    DRUG SAFETY, 2013, 36 (09) : 852 - 853
  • [34] Meta-analysis of TNF-alpha polymorphism in caucasian psoriatic arthritis populations
    Rahman, P
    Siannis, F
    Butt, C
    Farewell, V
    Peddle, L
    Pellet, F
    Gladman, D
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 325 - 325
  • [35] Meta-analysis of the efficacy and safety of TNF-α inhibitors in the management of psoriatic arthritis
    Saad, A. A.
    Ashcroft, D. M.
    Symmons, D. P. M.
    Noyce, P. R.
    RHEUMATOLOGY, 2007, 46 : I49 - I49
  • [36] Serious Infections Among Psoriatic Arthritis Patients Taking TNF Inhibitors Versus Non-TNF Biologics: A Systematic Review and Network Meta-Analysis
    Malik, Saad Ullah
    Muzaffar, Kinza
    Bilal, Jawad
    Faridi, Warda
    Muddassir, Salman
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [37] Integrated Efficacy Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis
    Nash, Peter
    Coates, Laura C.
    Fleischmann, Roy
    Papp, Kim
    Gomez-Reino, Juan J.
    Kanik, Keith S.
    Wang, Cunshan
    Wu, Joseph
    Hendrikx, Thijs
    Ports, William C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [38] Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis
    Maneiro, Jose Ramon
    Souto, Alejandro
    Salgado, Eva
    Mera, Antonio
    Gomez-Reino, Juan J.
    RMD OPEN, 2015, 1 (01):
  • [39] INTEGRATED EFFICACY ANALYSIS OF TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Nash, P.
    Coates, L. C.
    Fleischmann, R.
    Papp, K. A.
    Gomez-Reino, J. J.
    Kanik, K. S.
    Wang, C.
    Wu, J.
    Hendrikx, T.
    Ports, W. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 951 - 952
  • [40] The impact of bDMARDs on postoperative complications in patients with rheumatoid arthritis: A systematic review and meta-analysis
    Suto, Takahito
    Okamura, Koichi
    Sakane, Hideo
    Okura, Chisa
    Kaneko, Tetsuya
    Chikuda, Hirotaka
    MEDICINE, 2023, 102 (47) : E36132
12345